# Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

> **NCT00484900** · PHASE3 · COMPLETED · sponsor: **Dafra Pharma** · enrollment: 1390 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DRUG:** Co-Arinate FDC
- **DRUG:** Coartem

## Key facts

- **NCT ID:** NCT00484900
- **Lead sponsor:** Dafra Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 1390 (ACTUAL)
- **Last updated:** 2008-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484900, "Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00484900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*